MaxRS Ventures (AQSE:MAX) Accounts Receivable : £0.00 Mil (As of Oct. 2023)

View and export this data going back to 2019. Start your Free Trial

What is MaxRS Ventures Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. MaxRS Ventures's accounts receivables for the quarter that ended in Oct. 2023 was £0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding. MaxRS Ventures's Days Sales Outstanding for the quarter that ended in Oct. 2023 was 0.00.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. MaxRS Ventures's Net-Net Working Capital per share for the quarter that ended in Oct. 2023 was £-0.01.

MaxRS Ventures Accounts Receivable Historical Data

The historical data trend for MaxRS Ventures's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MaxRS Ventures Accounts Receivable Chart

MaxRS Ventures Annual Data

Trend

Oct19

Oct20

Oct21

Oct22

Oct23

Accounts Receivable

MaxRS Ventures Semi-Annual Data
	Oct19	Oct20	Oct21	Oct22	Oct23
Accounts Receivable	-	-	-	-	-

MaxRS Ventures Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

MaxRS Ventures Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

MaxRS Ventures's Days Sales Outstanding for the quarter that ended in Oct. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0.006	*	91
=	0.00

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), MaxRS Ventures's accounts receivable are only considered to be worth 75% of book value:

MaxRS Ventures's Net-Net Working Capital Per Share for the quarter that ended in Oct. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.015	+	0.75 * 0	+	0.5 * 0	-	0.129
-	0	-	0)	/	14.7924
=	-0.01

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

MaxRS Ventures Accounts Receivable Related Terms

Thank you for viewing the detailed overview of MaxRS Ventures's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

MaxRS Ventures (AQSE:MAX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » MaxRS Ventures Plc (AQSE:MAX) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Sloane Avenue, London, GBR, SW3 3DD

Website

https://www.maxrets.com

MaxRS Ventures Plc is an investment company that seeks to maximize returns for shareholders predominantly through capital appreciation, by investing in or acquiring distressed or out-of-favor assets that the Board believes have become undervalued or which may benefit from consolidation as a result of the current challenging economic and geopolitical landscape. The company's investment is currently focussed on four sectors comprising life sciences, fintech businesses and assets that use fintech, impact investing (environmental and renewables), and retail.